Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8552 |
High Similarity |
NPD1613 |
Approved |
0.8552 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8414 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.8345 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8344 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.8276 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8276 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8219 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.8207 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8024 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7987 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7931 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7917 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7904 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7904 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7891 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7838 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7815 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7792 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7792 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7791 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD1934 |
Approved |
0.773 |
Intermediate Similarity |
NPD37 |
Approved |
0.7719 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7711 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7697 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7697 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7697 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7665 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7661 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5735 |
Approved |
0.7635 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7635 |
Intermediate Similarity |
NPD8651 |
Approved |
0.763 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7619 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7616 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7614 |
Intermediate Similarity |
NPD4663 |
Approved |
0.7595 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD1653 |
Approved |
0.759 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7582 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7571 |
Intermediate Similarity |
NPD7906 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7543 |
Intermediate Similarity |
NPD7313 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7311 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7310 |
Approved |
0.7543 |
Intermediate Similarity |
NPD7312 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7516 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7309 |
Approved |
0.7486 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7486 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7471 |
Intermediate Similarity |
NPD3051 |
Approved |
0.747 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7443 |
Intermediate Similarity |
NPD4577 |
Approved |
0.7443 |
Intermediate Similarity |
NPD4578 |
Approved |
0.7429 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7427 |
Intermediate Similarity |
NPD2970 |
Approved |
0.7427 |
Intermediate Similarity |
NPD2969 |
Approved |
0.7425 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7412 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD4160 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.7401 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7401 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7394 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7384 |
Intermediate Similarity |
NPD27 |
Approved |
0.7384 |
Intermediate Similarity |
NPD2489 |
Approved |
0.7371 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7371 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7368 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7356 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7346 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD5327 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.7325 |
Intermediate Similarity |
NPD4536 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4538 |
Approved |
0.731 |
Intermediate Similarity |
NPD6671 |
Approved |
0.731 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7296 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7296 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7296 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7292 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7273 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7262 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD6353 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4097 |
Suspended |
0.726 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7247 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7247 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7244 |
Intermediate Similarity |
NPD4140 |
Approved |
0.7237 |
Intermediate Similarity |
NPD3094 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.7232 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7219 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7219 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7204 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD1091 |
Approved |
0.72 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.72 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7191 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7178 |
Intermediate Similarity |
NPD5058 |
Phase 3 |
0.7176 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.717 |
Intermediate Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD5588 |
Approved |
0.717 |
Intermediate Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD5960 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD7466 |
Approved |
0.716 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.716 |
Intermediate Similarity |
NPD5929 |
Approved |
0.716 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7159 |
Intermediate Similarity |
NPD8156 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.7152 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6072 |
Discontinued |
0.7135 |
Intermediate Similarity |
NPD7831 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7832 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD7833 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7041 |
Phase 2 |
0.7134 |
Intermediate Similarity |
NPD7040 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7115 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD8251 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8252 |
Approved |
0.7102 |
Intermediate Similarity |
NPD8099 |
Discontinued |
0.7099 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7099 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7089 |
Intermediate Similarity |
NPD3657 |
Discovery |
0.7086 |
Intermediate Similarity |
NPD3092 |
Approved |
0.7081 |
Intermediate Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.7076 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7073 |
Intermediate Similarity |
NPD7124 |
Phase 2 |
0.7069 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7069 |
Intermediate Similarity |
NPD6071 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7055 |
Intermediate Similarity |
NPD6331 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7055 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7055 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7055 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7048 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7048 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7047 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7034 |
Intermediate Similarity |
NPD228 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2238 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD2560 |
Approved |
0.7018 |
Intermediate Similarity |
NPD2563 |
Approved |
0.7012 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7012 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7985 |
Registered |
0.7 |
Intermediate Similarity |
NPD5722 |
Discontinued |
0.6988 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6988 |
Remote Similarity |
NPD7446 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD7843 |
Approved |
0.6982 |
Remote Similarity |
NPD6599 |
Discontinued |
0.6982 |
Remote Similarity |
NPD4675 |
Approved |
0.6982 |
Remote Similarity |
NPD4678 |
Approved |
0.6981 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6975 |
Remote Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.6975 |
Remote Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD3705 |
Approved |
0.6968 |
Remote Similarity |
NPD4624 |
Approved |
0.6954 |
Remote Similarity |
NPD5126 |
Approved |
0.6954 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.6954 |
Remote Similarity |
NPD4666 |
Phase 3 |
0.6951 |
Remote Similarity |
NPD3750 |
Approved |
0.6947 |
Remote Similarity |
NPD2494 |
Approved |
0.6947 |
Remote Similarity |
NPD2493 |
Approved |
0.6946 |
Remote Similarity |
NPD7314 |
Clinical (unspecified phase) |
0.6944 |
Remote Similarity |
NPD2684 |
Approved |
0.6941 |
Remote Similarity |
NPD7411 |
Suspended |
0.694
|
Remote Similarity |
NPD8150 |
Discontinued |